Cargando…
Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers
BACKGROUND: Quantification of circulating organ-specific cell-free DNA (cfDNA) provides a sensitive measure of ongoing cell death that could benefit evaluation of the cholestatic liver diseases primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC), which lack reliable non-invasi...
Autores principales: | Punia, Sohan, Juran, Brian D., Ali, Ahmad H., Schlicht, Erik M., Moore, Raymond M., Sun, Zhifu, Lazaridis, Konstantinos N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017778/ https://www.ncbi.nlm.nih.gov/pubmed/33794792 http://dx.doi.org/10.1186/s12876-021-01741-5 |
Ejemplares similares
-
DNA methylation profile of liver tissue in end-stage cholestatic liver disease
por: Cheung, Angela C, et al.
Publicado: (2022) -
Genome-wide resolution peripheral blood methylome profiling reveals signatures for cholestatic liver disease
por: Moore, Raymond M, et al.
Publicado: (2020) -
High‐Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver Diseases
por: Walker, Douglas I., et al.
Publicado: (2021) -
Update on pharmacotherapies for cholestatic liver disease
por: Ali, Ahmad H., et al.
Publicado: (2016) -
Liver Transplantation for Patients with Cholestatic Liver Diseases
por: Schöning, Wenzel, et al.
Publicado: (2015)